MRVI Maravai LifeSciences Expected net earnings per share growth this year

MRVI (Maravai) - company brandmark

Maravai LifeSciences (MRVI) combines its dominance in nucleotide synthesis and the development of the CleanCap base with a planned expansion of R&D capacities. The relative EPS YoY trend demonstrates earnings per share dynamics, where the value is fixed at 76.20. The company acts as a biomedical innovator, creating benchmark components for gene therapy and modern mRNA drugs.

Maravai LifeSciences Holdings, Inc. (MRVI): Earnings growth in current year from 07/04/2022 to 11/18/2026

Financial and market metric breakdowns for maravai.com (MRVI)

- current quotes and average value forecast:
Summary company analysis:Maravai LifeSciences Corp, MRVI
Manufactured products of Maravai LifeSciences

The assessment of asset reliability is based on an analysis of the business's ability to convert revenue into net income per share. This indicator measures the annual growth rate of EPS, confirming the effectiveness of the monetization of CleanCap patents and royalties from mRNA vaccines, which allows the year-over-year EPS dynamics to determine the resilience of Maravai LifeSciences (MRVI) to market volatility.

Direct competitors

Net earnings per share change in current year Agilent Tech A|Earnings per share growth in current year Quest Corp|Illumina, Inc. (ILMN) - Expected net earnings per share growth this year|Earnings growth in current year EXAS|RVTY (Revvity) - Earnings per share increase in current year|Earnings per share growth in current year bio-rad.com BIO|NNNN: Earnings per share growth this year|Sotera Health Corp - Earnings growth in current year|Expected net earnings per share growth this year QuidelOrtho QDEL|OPK (OPKO Health) - Net earnings per share growth this year|Earnings per share growth rate in current year CareDx, Inc. (CDNA)|FLGT (fulgentgenetics.com) - Earnings growth in current year|Earnings growth in current year Standard BioTools Corp|Net earnings per share growth this year CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Earnings per share increase in current year|Earnings growth in current year XGN (exagen.com)|MDxHealth Inc. - Earnings per share growth in current year|Lucid Diagnostics, Inc - Earnings growth in current year|Expected net earnings per share growth this year Prenetics Global Limited PRE|Insight Molecular (IMDX) - Earnings per share growth in current year|TRIB (Trinity Biotech PLC) - Earnings per share growth in current year|Earnings per share growth in current year ProPhase Labs|Ainos (AIMD) - Expected net earnings per share growth this year|Net earnings per share growth this year CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Earnings per share increase in current year|Earnings per share growth in current year Biomerica BMRA|CDIO: Earnings per share growth this year|Onconetix Inc - Earnings growth in current year|Expected net earnings per share growth this year Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Earnings per share growth in current year|Vermillion - Earnings per share increase in current year|AXDX (Accelerate Diagnostics Inc) - Earnings growth in current year|Net earnings per share growth this year CENTOGENE, N.V. (CNTG)|Net earnings per share growth this year ENZ (Enzo)|Earnings growth in current year Fresh2 Group Limited (FRES)|Earnings growth in current year GENE (GTG Labs)|ME - Net earnings per share growth this year|Psychemedics Inc - Earnings growth in current year